Letter: loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease-authors' reply

Aliment Pharmacol Ther. 2022 Feb;55(4):499-500. doi: 10.1111/apt.16757.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Chronic Disease
  • Duration of Therapy*
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy